Orlistat Capsules 120mg are indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m2, or overweight patients (BMI ≥ 28 kg/m2) with associated risk factors.
Treatment with orlistat should be discontinued after 12 weeks if patients have been unable to lose at least 5% of the body weight as measured at the start of therapy.
If you are a distributor, please inquirewith us about product registration, importing and/or marketing our products inyour country or region.
If you are a consumer, don't hesitate to contact us aboutmore information for this product.
Product Categories : Finished Pharmaceutical Products > Digestive System